INTRODUCTIONThe exposure of human skin to solar ultraviolet radiation (UVR) results in the formation of DNA and protein photolesions that can give rise to photoaging and non-melanoma skin cancers (NMSC).1-3…

INTRODUCTION Papulopustular rosacea (PPR) is a chronic inflammatory disorder characterized by facial papules, pustules, and persistent erythema.1 It is highly prevalent and associated with adverse impact on quality of life…

INTRODUCTION Rosacea is a common disorder affecting 16 million people in the US alone.1 Despite earlier beliefs that rosacea was primarily a disease of light-skinned Caucasian, middle-aged women, we now…

INTRODUCTIONOutcomes in dermatology have traditionally been measured via clinician assessment. However, the patient’s perspective is increasingly recognized as valuable in externally visible skin diseases, as these conditions substantially impact health-related…

INTRODUCTIONBiologic medications have been thoroughly tested in clinical trials and have well documented efficacy in the treatment of chronic plaque psoriasis. However, there is less data for use in other…

INTRODUCTIONRiehl melanosis is a rare cause of skin hyperpigmentation that typically occurs on the face and neck and is characterized by the rapid onset of gray-brown reticular pigmentation. The condition…

INTRODUCTION Bullous pemphigoid (BP) is a chronic, subepidermal autoimmune blistering skin disease characterized by the presence of IgG and C3 antibodies specific for hemidesmosomes, which promote dermo-epidermal adhesion.4 The reported…

INTRODUCTION Melasma is a common pigmentary disorder resulting in irregular patches of darkened skin on sun-exposed areas, particularly the cheeks, forehead, upper lip, nose and chin. This symmetric hypermelanosis is…

Skin Tightening with ThermiThermiAestheticsTM Southlake, TX, announced the publication of a clinical study analyzing the ThermiRFTM system, the first FDA cleared temperature controlled radiofrequency system designed for cosmetic applications. The…

Dr. Alan R. Shalita, who served as Senior Editor of the Journal of Drugs in Dermatology since its inception in 2001, died on February 2. Dr. Shalita was a distinguished…

Topical Therapies Topical treatment of hyperpigmentation is largely aimed at reducing the production and distribution of epidermal pigment. The tyrosinase inhibitor, hydroquinone, has long been the gold standard topical agent…

INTRODUCTION My participation in the IMCAS (International Master Class on Aging Skin) congresses began at the 2011 annual meeting in Paris, with a couple of short lectures on filler science…